Clinical Decisions | Doctor, How Long Should I Isolate?
Doctor, How Long Should I Isolate? – New England Journal of Medicine
The post Clinical Decisions | Doctor, How Long Should I Isolate? appeared first on Links Medicus.
Attributes and predictors of long COVID
Attributes and predictors of long COVID – Nature Commentary on Twitter Attributes and predictors of long COVID (fatigue, headache, dyspnea and anosmia) from 4182 incident cases. – 13.3% symptoms ≥4 wks– 4.5% for ≥8 wks – 2.3% for ≥12 wks Being older, female, incr. BMI, # symptoms all appeared to predict long COVID https://t.co/xSdNtLQO4V […]
The post Attributes and predictors of long COVID appeared first on Links Medicus.
Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk
Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Association of Anaesthetists of Great Britain and Ireland Original study: Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study – Anaesthesia Commentary on Twitter Reported by > 100 news […]
The post Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk appeared first on Links Medicus.
State of the Art Review | Severe covid-19 pneumonia: pathogenesis and clinical management
Severe covid-19 pneumonia: pathogenesis and clinical management – The BMJ
The post State of the Art Review | Severe covid-19 pneumonia: pathogenesis and clinical management appeared first on Links Medicus.
Death rate 64% higher with B117 COVID variant, study finds
Death rate 64% higher with B117 COVID variant, study finds – CIDRAP News release: Variant B.1.1.7 of COVID-19 associated with a significantly higher mortality rate, research shows – University of Bristol Original Study: Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study – The BMJ
The post Death rate 64% higher with B117 COVID variant, study finds appeared first on Links Medicus.
[Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19
Press release: Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19 Commentary: Eli Lilly’s combo therapy for COVID-19 cuts serious illness and death in large study – Reuters
The post [Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19 appeared first on Links Medicus.
[Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv Commentary on Twitter (thread – click for more) RECOVERY Pre-print: Convalescent plasma does not improve survival in patients hospitalised with COVID-19 in this randomised controlled trial involving 11,558 patients:https://t.co/36YZwJNY3Q pic.twitter.com/sKR095n1PC — Martin Landray (@MartinLandray) March 10, […]
The post [Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19 appeared first on Links Medicus.
Opinion | The Differences Between the Vaccines Matter
The Differences Between the Vaccines Matter – Vox
The post Opinion | The Differences Between the Vaccines Matter appeared first on Links Medicus.
Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster – The Lancet Original study and news release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
The post Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster appeared first on Links Medicus.
The role of C-reactive protein as a prognostic marker in COVID-19
The role of C-reactive protein as a prognostic marker in COVID-19 – International Journal of Epidemiology
The post The role of C-reactive protein as a prognostic marker in COVID-19 appeared first on Links Medicus.